Ubiquinone supplementation during lovastatin treatment: effect on LDL oxidation ex vivo1

Ubiquinone supplementation during lovastatin treatment: effect on LDL oxidation ex vivo1

A randomized, double-masked, placebo-controlled cross-over trial was carried out to evaluate whether ubiquinone supplementation (180 mg daily) corrects impaired defence against initiation of oxidation of low density lipoprotein (LDL) related to effective (60 mg daily) lovastatin treatment. Nineteen...

Full description

Bibliographic Details
Main Authors: Ari Palomäki, Kimmo Malminiemi, Tiina Solakivi, Outi Malminiemi
Format: Article
Language:English
Published: Elsevier 1998-07-01
Series:Journal of Lipid Research
Subjects:
AMVN
α-tocopherol
clinical trial
coenzyme Q10
copper-induced oxidation
HMG-CoA reductase inhibitors
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520325244

Internet

http://www.sciencedirect.com/science/article/pii/S0022227520325244

Similar Items